NEW YORK CITY, NY / ACCESS Newswire / January 24, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Klarna Group plc (NYSE:KLAR) pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with Klarna’s September 2025 initial public offering […]

(NASDAQ:VRNS), Were you affected by investment losses in VRNS common stock between February 4, 2025, and October 28, 2025? Affected Investor Losses Summary Varonis Systems, Inc. securities class action filed Purchasers or acquirers of Varonis Systems, Inc. (NASDAQ: VRNS) common stock Seeking recovery of investment losses for material misstatements and/or omissions (as alleged) from February

Varonis Systems, Inc. (VRNS) Investors: March 9, 2026 Filing Deadline in Securities Class Action – Contact Kessler Topaz Meltzer & Check, LLP GlobeNewswire January 24, 2026 Were you affected by investment losses in VRNS common stock between February 4, 2025, and October 28, 2025? Affected Investor Losses Summary Varonis Systems, Inc. securities class action filed

NEW YORK CITY, NY / ACCESS Newswire / January 24, 2026 / Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or the "Company") (NASDAQ:RXST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether RxSight and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / January 24, 2026 / Pomerantz LLP is investigating claims on behalf of investors of SNDL Inc. ("SNDL" or the "Company") (NASDAQ:SNDL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether SNDL and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / January 24, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (NASDAQ:VNDA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Vanda and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / January 24, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. ("Atara" or the "Company") (NASDAQ:ATRA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Atara and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / January 24, 2026 / Pomerantz LLP is investigating claims on behalf of investors of BigBear.ai Holdings, Inc. ("BigBear" or the "Company") (NYSE:BBAI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether BigBear and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / January 24, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Wealthfront Corporation ("Wealthfront" or the "Company") (NASDAQ:WLTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Wealthfront and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / January 24, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Ramaco Resources, Inc. ("Ramaco" or the "Company") (NASDAQ:METC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ramaco and certain of its officers and/or